(VIANEWS) - CF Industries Holdings (CF), Tenaris S.A. (TS), Vivaldi Asset Management, LLC (ADC) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. CF Industries Holdings (CF)
49.3% sales growth and 9.32% return on equity
CF Industries Holdings, Inc. manufactures and distributes nitrogen fertilizers and other nitrogen products worldwide.
CF Industries Holdings's sales growth this year is expected to be 36.9% and a negative 1% for next year.
Year-on-year quarterly revenue growth grew by 7.9%, now sitting on 4.2B for the twelve trailing months.
Volume
Today's last reported volume for CF Industries Holdings is 2020780 which is 9% below its average volume of 2220720.
CF Industries Holdings's sales growth for the next quarter is 49.3%. The company's growth estimates for the current quarter and the next is 1023.1% and 267.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.32%.
Volatility
CF Industries Holdings's last day, last week, and last month's current volatility was 8.08%, 2.57%, and 2.01%, respectively.
CF Industries Holdings's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.51% (day), 2.57% (last week), and 3.16% (last month), respectively.
CF Industries Holdings's Stock Yearly Top and Bottom Value
CF Industries Holdings's stock is valued at $50.42 at 16:22 EST, way under its 52-week high of $57.19 and way higher than its 52-week low of $25.30.
CF Industries Holdings's Moving Average
CF Industries Holdings's value is above its 50-day moving average of $46.91 and higher than its 200-day moving average of $48.97.2. Tenaris S.A. (TS)
48.8% sales growth and 4.03% return on equity
Tenaris S.A., through its subsidiaries, produces and sells seamless and welded steel tubular products; and provides related services for the oil and gas industry, and other industrial applications.
Tenaris S.A.'s sales growth this year is anticipated to be 15.3% and 18.3% for next year.
Year-on-year quarterly revenue growth grew by 23.2%, now sitting on 4.85B for the twelve trailing months.
Volume
Today's last reported volume for Tenaris S.A. is 2114790 which is 13.98% above its average volume of 1855240.
Tenaris S.A.'s sales growth for the next quarter is 48.8%. The company's growth estimates for the present quarter and the next is 666.7% and 100%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.03%.
Volatility
Tenaris S.A.'s last day, last week, and last month's current volatility was 1.12%, 2.20%, and 1.70%, respectively.
Tenaris S.A.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.16% (day), 2.30% (last week), and 2.26% (last month), respectively.
Tenaris S.A.'s Stock Yearly Top and Bottom Value
Tenaris S.A.'s stock is valued at $20.61 at 16:22 EST, way under its 52-week high of $24.15 and way above its 52-week low of $8.86.
Tenaris S.A.'s Moving Average
Tenaris S.A.'s value is above its 50-day moving average of $20.01 and below its 200-day moving average of $21.54.3. Vivaldi Asset Management, LLC (ADC)
28.9% sales growth and 3.69% return on equity
Vivaldi Asset Management, LLC's sales growth this year is expected to be 35.8% and 23.5% for next year.
Year-on-year quarterly revenue growth grew by 43.5%, now sitting on 295.6M for the twelve trailing months.
Volume
Today's last reported volume for Vivaldi Asset Management, LLC is 473534 which is 18.89% above its average volume of 398292.
Vivaldi Asset Management, LLC's sales growth for the next quarter is 28.9%. The company's growth estimates for the current quarter and the next is 17.9% and 9.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.69%.
Volatility
Vivaldi Asset Management, LLC's last day, last week, and last month's current volatility was 1.12%, 0.96%, and 0.88%, respectively.
Vivaldi Asset Management, LLC's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.68% (day), 1.89% (last week), and 1.61% (last month), respectively.
Vivaldi Asset Management, LLC's Stock Yearly Top and Bottom Value
Vivaldi Asset Management, LLC's stock is valued at $67.29 at 16:22 EST, way under its 52-week high of $75.95 and higher than its 52-week low of $61.27.
Vivaldi Asset Management, LLC's Moving Average
Vivaldi Asset Management, LLC's value is below its 50-day moving average of $72.84 and under its 200-day moving average of $71.14.4. TrueBlue (TBI)
12.2% sales growth and 9.02% return on equity
TrueBlue's sales growth this year is anticipated to be 15.2% and 8% for next year.
Year-on-year quarterly revenue growth grew by 43.7%, now sitting on 1.97B for the twelve trailing months.
Volume
Today's last reported volume for TrueBlue is 225021 which is 49.4% above its average volume of 150609.
TrueBlue's sales growth for the next quarter is 12.2%. The company's growth estimates for the current quarter and the next is 145.8% and 21.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.02%.
Volatility
TrueBlue's last day, last week, and last month's current volatility was 1.34%, 0.81%, and 1.20%, respectively.
TrueBlue's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.83% (day), 2.15% (last week), and 2.43% (last month), respectively.
TrueBlue's Stock Yearly Top and Bottom Value
TrueBlue's stock is valued at $28.59 at 16:22 EST, below its 52-week high of $29.99 and way higher than its 52-week low of $14.99.
TrueBlue's Moving Average
TrueBlue's worth is above its 50-day moving average of $26.97 and higher than its 200-day moving average of $26.23.5. AbbVie (ABBV)
8.8% sales growth and 48.86% return on equity
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally.
AbbVie's sales growth this year is anticipated to be 23% and 6% for next year.
Year-on-year quarterly revenue growth grew by 33.9%, now sitting on 53.73B for the twelve trailing months.
Volume
Today's last reported volume for AbbVie is 8609790 which is 21.85% above its average volume of 7065710.
AbbVie's sales growth for the next quarter is 8.8%. The company's growth estimates for the current quarter and the next is 14.5% and 13.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 48.86%.
Volatility
AbbVie's last day, last week, and last month's current volatility was 1.13%, 2.55%, and 1.23%, respectively.
AbbVie's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.64% (day), 4.64% (last week), and 2.23% (last month), respectively.
AbbVie's Stock Yearly Top and Bottom Value
AbbVie's stock is valued at $109.09 at 16:22 EST, way below its 52-week high of $121.53 and way above its 52-week low of $79.11.
AbbVie's Moving Average
AbbVie's value is below its 50-day moving average of $112.42 and under its 200-day moving average of $112.78.Previous days news about AbbVie(ABBV)
- According to Bloomberg Quint on Tuesday, 28 September, "The licensing deal would aim to replicate the success of last year's $2.9 billion deal with AbbVie Inc., people familiar with the matter have said."
- According to Business Insider on Wednesday, 29 September, "Allergan Aesthetics, an AbbVie company, and SkinBetter Science through their DREAMTM (Driving Racial Equity in Aesthetic Medicine) initiative are supporting the development and distribution of The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas, a dermatology atlas that will display images of the most commonly seen dermatology conditions in an array of skin tones. ", "At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. "
- AbbVie presents late-breaking data on risankizumab (skyrizi®) in psoriatic arthritis at the 30th European academy of dermatology and venereology (eadv) congress. According to Business Insider on Thursday, 30 September, "In January 2021, AbbVie announced positive top-line results from the Phase 3 KEEPsAKE-1 and KEEPsAKE-2 studies, showing that risankizumab (150 mg) achieved the primary endpoint of ACR20 response versus placebo during the 24-week double-blinded, placebo-controlled, parallel-group period (period 1).2,3", "Risankizumab (SKYRIZI) is part of a collaboration between Boehringer Ingelheim and AbbVie, with AbbVie leading development and commercialization globally."
6. Sensata Technologies Holding N.V. Ordinary Shares (ST)
5.1% sales growth and 13.5% return on equity
Sensata Technologies Holding plc, through its subsidiaries, develops, manufactures, and sells sensors, sensor-based solutions, controls, and other products in the Americas, Europe, Asia, and internationally.
Sensata Technologies Holding N.V. Ordinary Shares's sales growth this year is expected to be 25.5% and 8.1% for next year.
Year-on-year quarterly revenue growth grew by 72.2%, now sitting on 3.63B for the twelve trailing months.
Volume
Today's last reported volume for Sensata Technologies Holding N.V. Ordinary Shares is 749498 which is 0.89% below its average volume of 756303.
Sensata Technologies Holding N.V. Ordinary Shares's sales growth for the next quarter is 5.1%. The company's growth estimates for the present quarter and the next is 30.3% and 4.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.5%.
Volatility
Sensata Technologies Holding N.V. Ordinary Shares's last day, last week, and last month's current volatility was 3.84%, 1.88%, and 1.13%, respectively.
Sensata Technologies Holding N.V. Ordinary Shares's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.75% (day), 2.49% (last week), and 2.14% (last month), respectively.
Sensata Technologies Holding N.V. Ordinary Shares's Stock Yearly Top and Bottom Value
Sensata Technologies Holding N.V. Ordinary Shares's stock is valued at $56.06 at 16:22 EST, way under its 52-week high of $64.80 and way higher than its 52-week low of $42.52.